Literature DB >> 2788282

Human interleukin 6 is a direct promoter of maturation of megakaryocytes in vitro.

T Ishibashi1, H Kimura, T Uchida, S Kariyone, P Friese, S A Burstein.   

Abstract

The response of cells of the murine megakaryocytic lineage to human interleukin 6 (IL-6) was assessed in serum-depleted cultures using a variety of biological assays. IL-6 alone had no influence on megakaryocytic colony formation but augmented the numbers of these colonies induced by the multipotent colony-stimulating factor interleukin 3. However, in liquid marrow cultures, IL-6 alone promoted marked increments in megakaryocytic size and the activity of acetyl-cholinesterase, a marker enzyme of the lineage. Moreover, IL-6 induced a significant shift toward higher ploidy classes when megakaryocytic DNA was quantitated by flow cytometry. To determine whether the influence of IL-6 on megakaryocytic maturation was direct, the factor was added to cultures of single megakaryocytes isolated from megakaryocytic colonies. Fifty-four percent of these cells increased in size compared with 19% of those grown without IL-6. The data show that human IL-6 is a potent direct-acting growth factor for murine megakaryocytes with activity promoting maturation of that lineage.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2788282      PMCID: PMC297749          DOI: 10.1073/pnas.86.15.5953

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Characteristics of murine megakaryocytic colonies in vitro.

Authors:  S A Burstein; J W Adamson; D Thorning; L A Harker
Journal:  Blood       Date:  1979-07       Impact factor: 22.113

Review 2.  Megakaryocytopoiesis and platelet production: a review.

Authors:  E M Mazur
Journal:  Exp Hematol       Date:  1987-05       Impact factor: 3.084

Review 3.  Molecular regulation of B lymphocyte response.

Authors:  T Kishimoto; T Hirano
Journal:  Annu Rev Immunol       Date:  1988       Impact factor: 28.527

4.  Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon-beta 2.

Authors:  L Chen; Y Mory; A Zilberstein; M Revel
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

5.  Regulation of thrombopoiesis: effects of the degree of thrombocytopenia on megakaryocyte ploidy and platelet volume.

Authors:  L Corash; H Y Chen; J Levin; G Baker; H Lu; Y Mok
Journal:  Blood       Date:  1987-07       Impact factor: 22.113

6.  Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin.

Authors:  T Hirano; K Yasukawa; H Harada; T Taga; Y Watanabe; T Matsuda; S Kashiwamura; K Nakajima; K Koyama; A Iwamatsu
Journal:  Nature       Date:  1986 Nov 6-12       Impact factor: 49.962

7.  Biochemical characterization of an in-vitro murine megakaryocyte growth activity: megakaryocyte potentiator.

Authors:  S H Oon; N Williams
Journal:  Leuk Res       Date:  1986       Impact factor: 3.156

8.  B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes.

Authors:  Y Takai; G G Wong; S C Clark; S J Burakoff; S H Herrmann
Journal:  J Immunol       Date:  1988-01-15       Impact factor: 5.422

9.  Quantitation of megakaryocytopoiesis in liquid culture by enzymatic determination of acetylcholinesterase.

Authors:  S A Burstein; C N Boyd; G L Dale
Journal:  J Cell Physiol       Date:  1985-01       Impact factor: 6.384

10.  Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining.

Authors:  A Krishan
Journal:  J Cell Biol       Date:  1975-07       Impact factor: 10.539

View more
  67 in total

1.  Manipulations of cholinesterase gene expression modulate murine megakaryocytopoiesis in vitro.

Authors:  D Patinkin; S Seidman; F Eckstein; F Benseler; H Zakut; H Soreq
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

Review 2.  Animal models for the biological effects of continuous high cytokine levels.

Authors:  M Lübbert; D Jonas; F Herrmann
Journal:  Blut       Date:  1990-11

Review 3.  Interleukin-6 and the acute phase response.

Authors:  P C Heinrich; J V Castell; T Andus
Journal:  Biochem J       Date:  1990-02-01       Impact factor: 3.857

4.  Engineering human interleukin-6 to obtain variants with strongly enhanced bioactivity.

Authors:  C Toniatti; A Cabibbo; E Sporena; A L Salvati; M Cerretani; S Serafini; A Lahm; R Cortese; G Ciliberto
Journal:  EMBO J       Date:  1996-06-03       Impact factor: 11.598

Review 5.  The molecular mechanisms that control thrombopoiesis.

Authors:  Kenneth Kaushansky
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

6.  Platelet activation and platelet-leukocyte aggregation elicited in experimental colitis are mediated by interleukin-6.

Authors:  Serena L S Yan; Janice Russell; D Neil Granger
Journal:  Inflamm Bowel Dis       Date:  2014-02       Impact factor: 5.325

Review 7.  Therapy of rheumatoid arthritis by blocking IL-6 signal transduction with a humanized anti-IL-6 receptor antibody.

Authors:  K Yoshizaki; N Nishimoto; M Mihara; T Kishimoto
Journal:  Springer Semin Immunopathol       Date:  1998

8.  Operative stress potentiates the inductivity of membrane associated lymphotoxin (mLT) on lymphokine activated killer (LAK) cells in vitro.

Authors:  A Horiuchi; Y Abe; M Miyake; K Kimura; Y Osuka; S Kimura
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

9.  An assessment of myeloid colony-forming-cell generation in liquid human bone marrow cultures: influence of accessory cells and cytokines IL-1 alpha, beta and IL-6.

Authors:  R P Gooding; P G Riches; M Y Gordon
Journal:  Int J Exp Pathol       Date:  1993-04       Impact factor: 1.925

10.  Defective production of interleukin-6 in very small premature infants in response to bacterial pathogens.

Authors:  A Yachie; N Takano; K Ohta; T Uehara; S Fujita; T Miyawaki; N Taniguchi
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.